Skip to content
In English |
En español
Search
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-14 of 14 for your search:
Cancer Type/Condition:
Breast cancer, female
Stage/Subtype:
inflammatory breast cancer
Country:
U.S.A.
Trial Type:
Treatment
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase II/III Study of Neoadjuvant Therapy Comprising Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) (Abraxane®) in Women With Previously Untreated, Unresected, Stage II-IIIB Breast Cancer
Phase:
Phase III, Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WHC-MRI-GU-2006-097
, NCT00397761
2.
Phase 1/2 Study of ThermoDox With Approved Hyperthermia in Treatment of Breast Cancer Recurrence at the Chest Wall
Phase:
Phase II, Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
105-08-201
, NCT00826085
3.
Phase II Study of Tandem High-Dose Chemotherapy Comprising Melphalan, Carboplatin, Thiotepa, and Cyclophosphamide With or Without Trastuzumab (Herceptin®) Followed By Autologous Peripheral Blood Stem Cell Transplantation and Helical Tomotherapy or Loco-Regional Radiotherapy in Patients With High-Risk Stage IIIB, IIIC, or IV Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
65 and under
Sponsor:
NCI
Protocol IDs:
CHNMC-05042
, IRB 05042, NCT00182793
4.
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
0903-882
, 0309006307, NCT00195091
5.
Phase II Randomized Study of Neoadjuvant Docetaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Versus Doxorubicin and Cyclophosphamide Followed By Paclitaxel and Carboplatin With or Without Trastuzumab (Herceptin®) in Patients With Stage II or III Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CHNMC-05015
, IRB 05015, NCT00295893
6.
Phase II Study of Neoadjuvant Oxidized Glutathione (NOV-002), Doxorubicin Hydrochloride, and Cyclophosphamide Followed by Docetaxel in Women with Newly Diagnosed, Previously Untreated, Stage IIB or IIIC Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
MUSC-101072
, MUSC-HR-17111, 101072, NCT00499122
7.
Phase II Study of Neoadjuvant Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim (G-CSF) in Patients With Stage IIB-IIIC Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UWCC-6488
, 6488, UWCC-UW-6488, UWCC-07-6437-H/A, NCT00513695
8.
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
19 and over
Sponsor:
Other
Protocol IDs:
F061229006
, UAB 0648, NCT00530868
9.
Phase II Trial of Neoadjuvant Metronomic Chemotherapy in Triple-Negative Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 to 75
Sponsor:
Other
Protocol IDs:
LJCC 07-03
, NCT00542191
10.
Phase II Neoadjuvant in Inflammatory Breast Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
2007-0818
, NCT00756470
11.
Treatment With Pazopanib for Neoadjuvant Breast Cancer
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
110264
, NSABP FB-6, NCT00849472
12.
Study of XL184 in Adults With Advanced Malignancies
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
XL184-203
, NCT00940225
13.
Phase I Study of Temperature-Sensitive Liposomal Doxorubicin (ThermoDox™) in Combination With Hyperthermia in Women With Locally Recurrent Breast Cancer
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
DUMC-6883-06-2R1
, DUMC-06068, NCT00346229
14.
Dose-escalation Study of Oral CX-4945
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
C4-08-001
, NCT00891280
Select All on Page
Help with Results
